Fecal microbiota transplantation in ulcerative colitis

Area of Science:

• Gastroenterology
• Microbiome Research
• Immunology

Background:

• Fecal microbiota transplantation (FMT) is a procedure to restore gut microbiota balance.
• FMT has shown high success rates for recurrent Clostridium difficile infections.
• Ulcerative colitis (UC) is a chronic inflammatory bowel disease with limited treatment options.

Purpose of the Study:

• To evaluate the safety and efficacy of FMT in treating ulcerative colitis.
• To explore characteristics of potential 'super donors' for FMT.

Main Methods:

• A systematic literature search was conducted on PubMed using terms related to FMT and inflammatory bowel disease.
• Studies focusing on FMT for UC treatment were included, comprising case reports, open-label trials, randomized controlled trials (RCTs), and a meta-analysis.
• 31 original studies and 1 meta-analysis were analyzed.

Main Results:

• Four RCTs indicate FMT is effective for UC, with clinical remission rates of 24-44% in FMT groups versus 5-20% in control groups.
• A meta-analysis confirmed significantly higher remission rates for FMT (42.1%) compared to controls (22.6%).
• Gut microbiota composition is crucial for successful FMT outcomes.

Conclusions:

• Fecal microbiota transplantation appears to be a safe and promising therapeutic option for managing ulcerative colitis.
• Larger cohort studies are necessary to confirm efficacy and establish optimal FMT protocols.